HLJ2 Effectively Ameliorates Colitis-Associated Cancer via Inhibition of NF-κB and Epithelial–Mesenchymal Transition

Схожие документы

• Colitis Is Effectively Ameliorated by (±)-8-Acetonyl-dihydrocoptisine via the XBP1-NF-κB Pathway
  по: Zhang, HaiJing, et al.
  Опубликовано: (2017)
• Butyric Acid Increases the Therapeutic Effect of EHLJ7 on Ulcerative Colitis by Inhibiting JAK2/STAT3/SOCS1 Signaling Pathway
  по: Tang, Xiaonan, et al.
  Опубликовано: (2020)
• CS-semi5 Inhibits NF-κB Activation to Block Synovial Inflammation, Cartilage Loss and Bone Erosion Associated With Collagen-Induced Arthritis
  по: Li, Xiang, et al.
  Опубликовано: (2021)
• Lovastatin derivative dehydrolovastatin ameliorates ulcerative colitis in mice by suppressing NF-κB and inflammatory cytokine expression
  по: Zhang, Xu, et al.
  Опубликовано: (2020)
• Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-κB/NLRP3-mediated epithelial–mesenchymal transition and inflammation
  по: Peng, Ling, et al.
  Опубликовано: (2020)